SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff

Intel VP: “We had 11 or 12 layers of management... now it’s 5 or 6”

From textile recycling to autonomous vessels: The vision behind the Dream Team startups

ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”

Buzz

Most popular

Daily

Weekly

1

Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing

2

Check Point raises $1.75 billion, potentially eyeing AI expansion

3

Hapag-Lloyd eyes ZIM acquisition, workers push back

4

Sequoia’s Shaun Maguire says Israel risks losing “a war it can’t see”

5

Cybereason founders' 7AI raises record $130 million Series A in breakneck rise

Blood Cancer

4 stories about Blood Cancer

אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer

The investment is part of a licensing option agreement signed between the two companies

פרופסור זליג אשחר

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18|Zohar Shahar Levy

Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17|Lilach Baumer

The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000